ArticleInvestigational new drugs2013
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib.
Grace K Dy et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleInvestigational new drugs2013
Grace K Dy et al.PubMed ↗Publisher ↗
No numbers read from the abstract.